Author:
Wu Xiao-long,Zhuang Hai-feng,Zhao Yan-na,Yu Xiao-ling,Dai Tie-ying,Gao Rui-lan
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference50 articles.
1. Martin G, Theodore G, Mary EDF, et al. Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant 2002;8:47–56.
2. Marie R, Raphaël P, Renato DCA, et al. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor. Biol Blood Marrow Transplant 2007;13:1304–1312.
3. Xu Y, Li L, Chen Y, et al. Role of HMGB1 in regulation of STAT3 expression in CD4+ T cells from patients with aGVHD after allogeneic hematopoietic stem cell transplantation. Clin Immunol 2015;161:278–283.
4. Jaebok C, Julie R, Julie LP, et al. In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. Blood 2010;116:129–139.
5. Anusara D, Supinya L, Paramita C, et al. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice. Blood 2019;133:266–279.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献